Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
Clin Ter ; 173(1): 35-38, 2022 Feb 07.
Article in English | MEDLINE | ID: mdl-35147644

ABSTRACT

CASE REPORT: A 14-year-old girl presented with 1 cm large whitened lesion on the ventral surface of the tongue, appeared from 1 month. Past history showed congenital dyserythropoietic anemia type II. The lesion was excised and microscopic and immunohistochemical analyses were compatible with benign Abrikossoff tumor. Total body MRI was negative. After six months the patient presented a second tongue lesion and four months later another large painful lesion in the soft palate, with the same istological diagnosis. In addition, she had other multiple lesions: two apperead at pharyngeal level (not biopsied) that remain stable over time, and one at the pituitary gland. CONCLUSION: Granular cell tumors, with or without multiple lesions, are rare in children. About 50% of cases involve the head and neck region, with the tongue being the most affected site. Therapy is based on the surgical excision of the lesions; however some tumor forms, although their histological aspect of benignity, often have an important infiltrative power, making the therapeutic approach difficult, as in our case.


Subject(s)
Anemia, Dyserythropoietic, Congenital , Granular Cell Tumor , Adolescent , Female , Granular Cell Tumor/complications , Granular Cell Tumor/surgery , Humans , Magnetic Resonance Imaging , Neoplasm Recurrence, Local
2.
Eur Rev Med Pharmacol Sci ; 25(1): 161-164, 2021 01.
Article in English | MEDLINE | ID: mdl-33506904

ABSTRACT

Extramedullary hematopoiesis (EMH) is a proliferation of hematopoietic tissue outside the bone marrow. The most affected areas are paravertebral ones. We report the case of a patient with homozygous Hb Lepore, not regularly transfused since the age of four years until the age of 29 years, when paravertebral heterotopic masses were first observed. After about 10 years she started reporting clinical signs suggestive of sinusitis. Computed tomography (CT) and Magnetic Resonance Imaging (MRI) showed heterotopic masses in the ethmoid and in the frontal sinuses. Involvement of the sinuses of the large facial area represents a rare localization of EMH. Various cases have been reported in patients with thalassemia intermedia, but no case has been reported with HbLepore. The diagnostic gold standard is MRI, which provides highly accurate and clear images. The treatment is based on hydroxyurea and/or an intensive transfusional regime and sometimes on surgery.


Subject(s)
Frontal Sinus/diagnostic imaging , Hematopoiesis, Extramedullary , Hemoglobins, Abnormal/analysis , Magnetic Resonance Imaging , Tomography, X-Ray Computed , Adult , Female , Humans
3.
Clin Ter ; 170(3): e163-e167, 2019.
Article in English | MEDLINE | ID: mdl-31173043

ABSTRACT

INTRODUCTION: Retinal vein occlusions (RVOs) are rare in the younger population. Hematological pro-thrombotic factors are thought to be important in a minority, amplifying an atherosclerotic anatomical predisposition. CASE REPORT: Anotherwise healthy 13-year-old girl presented two episodes of sudden decreased vision in few months.Ophthalmological exams pointed out post-thrombotic intra-retinal hemorrhage. All investigations were normal, thrombophilia screen showed factor XII deficiency and genetic mutations of methylenetetrahydrofolate reductase (MTHFR), angiotesin convertin enzyme (ACE) and angiotensinogen (AGT). Two intravitreal injection of bevacizumab was administered with improving visual acuity; subsequently the patient did not report further episodes. DISCUSSION: In addition to traditional factors with procoagulant activity, factor XII deficiency plays an important role in thrombosis's mechanism. Its deficiency causes a marked prolongation of the activated partial thromboplastin time in the laboratory examination. Moreover also MTHFR, ACE and AGT could have been involved in this case, so it is important to evaluate these parameters in the differential diagnosis of RVOs.


Subject(s)
Bevacizumab/administration & dosage , Retinal Vein Occlusion/drug therapy , Thrombophilia/genetics , Adolescent , Female , Humans , Intravitreal Injections , Mutation , Retinal Vein Occlusion/genetics , Thrombophilia/complications , Visual Acuity
4.
Clin Ter ; 165(5): 253-6, 2014.
Article in English | MEDLINE | ID: mdl-25366945

ABSTRACT

Scurvy, a disease caused by a deficiency of ascorbic acid (vitamin C), is not very common disease especially in pediatric age. In the late nineteenth century, instead, we assisted to increase incidence of this problem for the use of heated milk and convenience foods. We report two cases of scurvy: a child of 3 years old came to our observation for an important gums' stomatitis, fever, widespread petechiae and ecchymosis on the skin of the lower limbs; in the second moment he had pain in upper and lower limbs with difficulty in walking; a second child of 4 years came to our observation for pain lower limbs and maintained the posture of the legs down, inability to walking, with reduced muscle tone and trophism in all limbs; at the instrumental examination he had an alveolar hemorrhage. The two boys had a history of a diet completely lacking in fruits and vegetables; they were drinking almost only milk. They carried various laboratory and instrumental tests, in particular X-ray of lower limbs that showed "a thick sclerotic metaphyseal line with beak-like excrescences of tibiae and femur". The characteristic radiological appearance, the particular clinical aspects, the dietary history and the dosage of vitamin C, have led us to the diagnosis of scurvy. They started therapy with vitamin C and they had a progressive improvement in general condition.


Subject(s)
Ascorbic Acid/therapeutic use , Scurvy/diagnosis , Scurvy/drug therapy , Vitamins/therapeutic use , Child , Child, Preschool , Humans , Male , Pain/etiology , Pain/prevention & control , Treatment Outcome , Walking
5.
Pediatr Med Chir ; 36(3): 10, 2014 Jun 30.
Article in English | MEDLINE | ID: mdl-25573645

ABSTRACT

We describe a case of spontaneous gastric rupture in a child of 5 years old. The patient reached us in a serious condition; the anamnesis was negative for traumatic events or gastrointestinal disorders. An abdominal X-ray and CT scan revealed free air and fluid in the abdominal cavity, leading to the diagnosis of gastro-intestinal perforation. Submitted to urgent surgery, a rupture of the posterior wall of the stomach was found that was treated with gastrectomy "à la demande". The surgery follow-up was regular. Morphological and immunohistochemical study showed some muscular abnormalities of the muscular gastric wall.


Subject(s)
Gastrectomy , Intestinal Perforation/surgery , Stomach Rupture/surgery , Child, Preschool , Female , Gastrectomy/methods , Humans , Intestinal Perforation/diagnosis , Intestinal Perforation/etiology , Rupture, Spontaneous , Stomach/abnormalities , Stomach/surgery , Stomach Rupture/diagnosis , Treatment Outcome
10.
J Endocrinol Invest ; 28(4): 363-6, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15966511

ABSTRACT

We measured the final height (FH) of 25 short polytransfused thalassemia major (Th) patients (18 males) with a reduced GH reserve treated for 3.3 +/- 1.2 yr with recombinant GH (rhGH), 0.2 mg/kg/week sc. At baseline, all patients were clinically prepubertal; their chronological (CA) and bone ages (BA) were 13.6 +/- 2.0 and 11.4 +/- 1.6 yr, respectively. In 9 out of 18 males and 5 out of 7 females, the onset of puberty occurred spontaneously during the treatment. At the end of the rhGH administration, the height of the enrolled children was not significantly increased when calculated for CA (HxCA), while it was significantly decreased (p=0.004) when calculated for BA (HxBA); the BA increase (3.29 +/- 1.65 yr) was significantly higher (p<0.001) than the height age increase (2.16 +/- 0.98 yr). The FHxCA showed a significant increase (p=0.001) compared to both baseline and the end of therapy, while the FHxBA was significantly decreased (p<0.001) compared with the corresponding value at baseline. At the end of therapy, both HxCA and HxBA resulted positively related to the BA at baseline (r=0.50 and 0.42, p=0.012 and 0.034, respectively). FH was positively correlated with CA (r=0.63, p=0.001), BA (r=0.68, p<0.001) and HxBA (r=0.59, p=0.002) evaluated at baseline, and with both HxCA and HxBA (r=0.82 and 0.74, respectively, p<0.001), evaluated at the end of treatment. A negative correlation was found between FH and the length of treatment (r=-0.56, p=0.004). Our data seem to exclude that prolonged rhGH therapy could improve FH in Th patients; on the contrary, a negative effect may be hypothesized.


Subject(s)
Body Height , Human Growth Hormone/therapeutic use , beta-Thalassemia/complications , beta-Thalassemia/drug therapy , Adolescent , Child , Drug Administration Schedule , Female , Human Growth Hormone/pharmacology , Humans , Male , Puberty , Recombinant Proteins
11.
J Pediatr Endocrinol Metab ; 16 Suppl 2: 259-66, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12729401

ABSTRACT

Present transfusional regimen protocols increase the life expectancy of patients with beta-thalassemia major, but cause a progressive iron overload that can be prevented or limited only by appropriate iron chelation. Siderosis is responsible for the clinical complications of the disease. Short stature and hypogonadism are extremely frequent in patients with thalassemia. Many factors are responsible for short stature in patients with thalassemia, the most important of which are dysfunction of the GH-IGF-I axis and desferoxamine (DFX)-induced bone dysplasia. Hypogonadism is the most frequent endocrine complication, mostly due to gonadotrophins deficiency secondary to iron overload. Sex steroid treatment for induction of puberty and/or maintenance of sexual characteristics is necessary. Both short stature and hypogonadism are present in a significant percentage of bone marrow transplanted patients with thalassemia. Factors responsible for short stature are previous iron overload, liver impairment, DFX treatment, and toxicity of chemotherapeutic agents. In some patients absence of pubertal development is due to gonadotropin insufficiency, probably secondary to previous iron overload; other patients exhibit hypergonadotrophic hypogonadism due to the toxic effect of chemotherapeutic agents on the gonads. Both groups need hormonal replacement therapy. These data support the need for vigilant follow-up of patients with thalassemia before and after transplantation, in order to treat endocrine dysfunctions at the appropriate age.


Subject(s)
Puberty , beta-Thalassemia/physiopathology , Body Height , Bone Marrow Transplantation , Chelation Therapy , Growth , Humans , Hypogonadism/etiology , beta-Thalassemia/complications , beta-Thalassemia/pathology , beta-Thalassemia/therapy
12.
Minerva Pediatr ; 54(6): 623-30, 2002 Dec.
Article in Italian | MEDLINE | ID: mdl-12388953

ABSTRACT

In children and in adolescents, chest pain is relatively common and self-limiting. The close association between chest pain, cardiopathies and sudden death is the cause of intense anxiety in boys and their parents and even doctors. The most frequent causes of chest pain, the diagnosis and the eventual treatment are examined. Finally, the causes of chest pain due to drug abuse (in particular cocaine) and to CO poisoning are also examined. Good knowledge of the problem, an accurate anamnesis and a careful objective exam are useful to choose the most suitable treatment.


Subject(s)
Chest Pain/etiology , Adolescent , Female , Humans , Male , Musculoskeletal Diseases/complications , Respiration Disorders/complications
13.
J Pediatr Endocrinol Metab ; 11 Suppl 3: 811-6, 1998.
Article in English | MEDLINE | ID: mdl-10091151

ABSTRACT

Short stature and short trunk have been reported in thalassaemic patients. We report a study on stature and body proportions in 476 patients (2-36 years old) with beta-thalassaemia major, followed in 12 Italian centres. Auxological data (standing height, sitting height, subischial leg length, target height), haematological data (age at first transfusion, age at start of desferrioxamine [DFX] chelation, mean dose of DFX, ferritin values) and information regarding the presence of endocrine disorders and of bone lesions, were collected and analysed according to the age of the patients, in order to investigate the natural history of the disproportion and the role of siderosis, DFX toxicity and endocrine disorders. Our data indicate that about 18% of thalassaemic patients exhibit short stature; disproportion between the upper and lower body segments is present in 14%; however, a short trunk despite normal stature is present in another 40% of patients. This is due to a spinal growth impairment which starts in infancy and progressively aggravates. We think that a short trunk is peculiar to the disease itself; however, other factors such as hypogonadism, siderosis, or DFX-induced bone dysplasia are probably involved in aggravating the body disproportion in these patients.


Subject(s)
Body Constitution , Body Height , beta-Thalassemia/physiopathology , Adolescent , Adult , Aging , Blood Transfusion , Child , Child, Preschool , Deferoxamine/therapeutic use , Female , Ferritins/blood , Humans , Iron Chelating Agents/therapeutic use , Male , beta-Thalassemia/therapy
14.
Rev Soc Bras Med Trop ; 29(6): 599-602, 1996.
Article in Portuguese | MEDLINE | ID: mdl-9011887

ABSTRACT

Two patients with the acquired immunodeficiency syndrome (AIDS) developed psoriasis, one of them presenting the more severe form and the other one the milder form of the disease, were treated with zidovudine per oral via, 200mg 3 times a day. In the first case the therapeutical response was complete. No lesion was verified in the patient after 9 months under maintenance schedule. In the second case, despite the response being clear, after 6 months of treatment, the patient still presented furfuraceous scalings at limbs ever under the medication schedule.


Subject(s)
Acquired Immunodeficiency Syndrome/complications , Psoriasis/complications , Adult , Humans , Male , Psoriasis/pathology
15.
Am J Hematol ; 48(2): 128-9, 1995 Feb.
Article in English | MEDLINE | ID: mdl-7847328

ABSTRACT

Using a combination of oligonucleotide probes and restriction endonuclease enzymes, we characterize beta-thalassemic mutations in 91 homozygous patients and 86 unrelated carriers. Overall, 268 beta-thalassemic genes were obtained. Eleven beta-globin mutations were identified, confirming the wide molecular heterogeneity of beta-thalassemia in Calabria. Information from the present study represents the mainstay for the development of a program of early prenatal diagnosis by direct detection of mutations in Calabria.


Subject(s)
Mutation , Prenatal Diagnosis , beta-Thalassemia/genetics , Codon , Female , Frameshift Mutation , Heterozygote , Homozygote , Humans , Italy , Pregnancy , beta-Thalassemia/diagnosis
16.
Acta Haematol ; 84(2): 72-6, 1990.
Article in English | MEDLINE | ID: mdl-2120889

ABSTRACT

Sixty transfusion-dependent thalassemic patients were studied by simultaneous measurement of circulating thyroid hormones, basal thyroid-stimulating hormone (TSH) and TSH response to thyrotropin-releasing hormone with the aim of evaluating the frequency of hypothyroidism in such patients, and the relationship between hypothyroidism and compliance with treatment and iron overload. Thyroid failure was present in 31 of the 60 patients. A correlation was found between impairment of thyroid functions, duration of chronic hypoxia and the activities of various transaminases. The results of this study emphasize the importance of early evaluation of thyroid function in thalassemic patients and suggest that anemia and hypoxia may potentiate the toxicity of iron deposition in endocrine glands.


Subject(s)
Hypothyroidism/complications , Thalassemia/complications , Adolescent , Blood Transfusion , Chelation Therapy , Child , Female , Ferritins/blood , Hemoglobins/analysis , Humans , Hypothyroidism/blood , Iron/metabolism , Male , Pituitary Gland/physiology , Splenectomy , Thalassemia/blood , Thalassemia/therapy , Thyroid Gland/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...